154 related articles for article (PubMed ID: 15208656)
41. Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.
Amano Y; Ishikawa R; Sakatani T; Ichinose J; Sunohara M; Watanabe K; Kage H; Nakajima J; Nagase T; Ohishi N; Takai D
Biochem Biophys Res Commun; 2015 Feb; 457(3):457-60. PubMed ID: 25596129
[TBL] [Abstract][Full Text] [Related]
42. What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?
Turner SD; Alexander DR
Leukemia; 2005 Jul; 19(7):1128-34. PubMed ID: 15902287
[TBL] [Abstract][Full Text] [Related]
43. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
44. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G
Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201
[TBL] [Abstract][Full Text] [Related]
45. Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.
Choi YL; Takeuchi K; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Hamada T; Haruta H; Watanabe H; Kurashina K; Hatanaka H; Ueno T; Takada S; Yamashita Y; Sugiyama Y; Ishikawa Y; Mano H
Cancer Res; 2008 Jul; 68(13):4971-6. PubMed ID: 18593892
[TBL] [Abstract][Full Text] [Related]
46. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
[TBL] [Abstract][Full Text] [Related]
47. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
Vishwamitra D; Curry CV; Alkan S; Song YH; Gallick GE; Kaseb AO; Shi P; Amin HM
Mol Cancer; 2015 Feb; 14():53. PubMed ID: 25884514
[TBL] [Abstract][Full Text] [Related]
48. SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.
Vishwamitra D; Curry CV; Shi P; Alkan S; Amin HM
Neoplasia; 2015 Sep; 17(9):742-754. PubMed ID: 26476082
[TBL] [Abstract][Full Text] [Related]
49. t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma.
Rosenwald A; Ott G; Pulford K; Katzenberger T; Kühl J; Kalla J; Ott MM; Mason DY; Müller-Hermelink HK
Blood; 1999 Jul; 94(1):362-4. PubMed ID: 10381534
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).
Fujimoto J; Shiota M; Iwahara T; Seki N; Satoh H; Mori S; Yamamoto T
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4181-6. PubMed ID: 8633037
[TBL] [Abstract][Full Text] [Related]
51. Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity.
Leoncini L; Lazzi S; Scano D; Mura A; Onida A; Massarelli G; Tosi P; Barbini P; Cevenini G; Massai MR; Pileri S; Falini B; Giordano A; Kraft R; Laissue JA; Cottier H
Int J Cancer; 2000 Jun; 86(6):777-81. PubMed ID: 10842190
[TBL] [Abstract][Full Text] [Related]
52. The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.
Zhang Q; Wei F; Wang HY; Liu X; Roy D; Xiong QB; Jiang S; Medvec A; Danet-Desnoyers G; Watt C; Tomczak E; Kalos M; Riley JL; Wasik MA
Am J Pathol; 2013 Dec; 183(6):1971-80. PubMed ID: 24404580
[TBL] [Abstract][Full Text] [Related]
53. [Effect of Tyrosine Phosphorylation Sites of Oncogenic Protein NPM-ALK on Cell Cycle and Its Related Mechanisms].
Hu LL; Zhen H; Zhang XN; Zhou L; Amin HM; Shi P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1201-5. PubMed ID: 27531800
[TBL] [Abstract][Full Text] [Related]
54. CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.
Tokuda K; Eguchi-Ishimae M; Yagi C; Kawabe M; Moritani K; Niiya T; Tauchi H; Ishii E; Eguchi M
Genes Chromosomes Cancer; 2014 Jan; 53(1):78-89. PubMed ID: 24142740
[TBL] [Abstract][Full Text] [Related]
55. The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.
Simonitsch I; Polgar D; Hajek M; Duchek P; Skrzypek B; Fassl S; Lamprecht A; Schmidt G; Krupitza G; Cerni C
FASEB J; 2001 Jun; 15(8):1416-8. PubMed ID: 11387242
[No Abstract] [Full Text] [Related]
56. ALK-mediated Na+/H+ exchanger-dependent intracellular alkalinization: does it matter for oncogenesis?
Turturro F; Driscoll M; Friday E; Welbourne T
Haematologica; 2007 May; 92(5):706-7. PubMed ID: 17488701
[TBL] [Abstract][Full Text] [Related]
57. Malignant high-grade histological transformation of inflammatory myofibroblastic tumour associated with amplification of TPM3-ALK.
Zhang H; Erickson-Johnson M; Wang X; Bahrami A; Medeiros F; Lonzo ML; Oliveira AM
J Clin Pathol; 2010 Nov; 63(11):1040-1. PubMed ID: 20870660
[No Abstract] [Full Text] [Related]
58.
Xiao A; Shahmarvand N; Nagy A; Kumar J; Van Ziffle J; Devine P; Huang F; Lezama L; Li P; Ohgami RS
Front Oncol; 2023; 13():1174606. PubMed ID: 37305584
[TBL] [Abstract][Full Text] [Related]
59. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.
Hallberg B; Palmer RH
Nat Rev Cancer; 2013 Oct; 13(10):685-700. PubMed ID: 24060861
[TBL] [Abstract][Full Text] [Related]
60. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Engelman JA; Zejnullahu K; Mitsudomi T; Song Y; Hyland C; Park JO; Lindeman N; Gale CM; Zhao X; Christensen J; Kosaka T; Holmes AJ; Rogers AM; Cappuzzo F; Mok T; Lee C; Johnson BE; Cantley LC; Jänne PA
Science; 2007 May; 316(5827):1039-43. PubMed ID: 17463250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
